The Board of Directors of Terns Pharmaceuticals, Inc. (the "Company") has adopted the following policies and procedures to assist the Board in discharging its fiduciary duties and fulfilling its responsibilities, including providing effective oversight of the management of the Company and adhering to principles of sound corporate governance. These policies and procedures reflect the Board’s commitment to setting the highest standards of business conduct and ethics for the Company’s employees, officers and directors and to building long-term stockholder value with an emphasis on corporate governance. These policies and procedures are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | Research and Development Committee | |
---|---|---|---|---|
David Fellows Chairman of the Board | member Compensation Committee | chairperson Nominating and Corporate Governance Committee | ||
Amy Burroughs | ||||
Carl Gordon | member Nominating and Corporate Governance Committee | |||
Jeffrey B. Kindler | chairperson Compensation Committee | |||
Hongbo Lu | member Compensation Committee | member Research and Development Committee | ||
Jill M. Quigley Financial Expert | chairperson Audit Committee | member Nominating and Corporate Governance Committee | ||
Radhika Tripuraneni | member Audit Committee | chairperson Research and Development Committee | ||
Heather Turner | member Audit Committee |